Amanta Healthcare IPO Review, Details, Date, Price, and GMP
The Indian primary market continues to offer diverse investment opportunities, and the upcoming Initial Public Offering (IPO) of Amanta Healthcare Limited has garnered significant attention from investors. This Rajkot-based pharmaceutical company is a key player in the sterile liquid formulations segment and is now seeking to raise capital to fund its expansion plans and other corporate needs. This detailed blog post provides a comprehensive review of the Amanta Healthcare IPO, covering all the crucial details for potential investors.
 |
| Amanta Healthcare IPO Review |
About Amanta Healthcare Limited
Founded in 1994, Amanta Healthcare is a pharmaceutical company that specializes in developing, manufacturing, and marketing a wide range of sterile liquid products, including Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs). These products, which include IV fluids, diluents, ophthalmic solutions, and respiratory care products, are packed using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company also manufactures medical devices. With a strong presence in both the domestic and international markets, Amanta Healthcare has over 45 generic products registered in India and exports to over 20 countries across Africa, Latin America, and Europe. The company's strategic focus is on catering to hospitals, nursing homes, and government institutions through its vast distribution network.
Amanta Healthcare IPO Details
The Amanta Healthcare IPO is a book-built issue with a significant fresh issue component. Here's a breakdown of the key details:
- Issue Size: ₹126.00 Crore
- Fresh Issue: The entire IPO is a fresh issue of 1.00 crore shares.
- Face Value: ₹10 per equity share
- Listing: BSE, NSE
Objectives of the IPO
The funds raised from the IPO are planned for specific strategic purposes, including:
- Funding capital expenditure for setting up a new SteriPort manufacturing line.
- Funding the establishment of a new SVP manufacturing line.
- General corporate purposes.
Amanta Healthcare IPO Date and Price
Potential investors should be aware of the IPO timeline and pricing details. Here's a summary of the key dates and price band:
Key Dates
| IPO Activity | Date |
|---|---|
| IPO Open Date | September 1, 2025 |
| IPO Close Date | September 3, 2025 |
| Basis of Allotment Finalization | September 4, 2025 (Tentative) |
| Initiation of Refunds | September 8, 2025 (Tentative) |
| Credit of Shares to Demat Account | September 8, 2025 (Tentative) |
| IPO Listing Date | September 9, 2025 (Tentative) |
Price and Lot Size
| Details | Information |
|---|---|
| Price Band | ₹120 to ₹126 per equity share |
| Minimum Lot Size (Retail) | 119 shares |
| Minimum Investment (Retail) | ₹14,994 (at the upper price band) |
Amanta Healthcare IPO Review and Financials
A review of Amanta Healthcare's financials reveals a mixed performance with recent improvements. While the company's revenue has been relatively flat over the last three fiscal years, it has shown a significant turnaround in profitability. After reporting a net loss in FY23, the company posted a healthy profit after tax (PAT) in FY24 and a substantial increase in FY25. This turnaround is a positive sign for investors, demonstrating the company's ability to improve its margins. Key strengths include its large-scale manufacturing capabilities, diversified product portfolio, and established domestic and international distribution networks. However, potential investors should also be aware of the risks, such as high debt levels, dependence on a single manufacturing facility, and litigation related to product quality.
Amanta Healthcare IPO GMP (Grey Market Premium)
The Grey Market Premium (GMP) is an unofficial indicator of an IPO's demand in the unlisted market. While it should not be the sole basis for an investment decision, a positive GMP often suggests that the stock is expected to list at a premium. The GMP for Amanta Healthcare IPO has shown positive sentiment, indicating that the market anticipates a decent listing gain. It's a key factor for those looking for short-term listing gains, but long-term investors should focus on the company's fundamental strength and future growth prospects.
Frequently Asked Questions (FAQs)
Amanta Healthcare is a pharmaceutical company that manufactures and markets sterile liquid products, including IV fluids, ophthalmic solutions, and respiratory care products, using advanced ABFS and ISBM technologies. It also produces medical devices.
The IPO is scheduled to open for subscription on September 1, 2025, and will close on September 3, 2025.
The price band has been set at ₹120 to ₹126 per equity share.
A retail investor needs to apply for a minimum of one lot, which consists of 119 shares. The minimum investment at the upper price band would be ₹14,994.
The allotment status is expected to be finalized on September 4, 2025. You can check it online on the website of the IPO registrar, MUFG Intime India Pvt. Ltd. You will need your PAN number, application number, or DP/Client ID to check the status.
The shares are tentatively scheduled to be listed on the BSE and NSE on September 9, 2025.
0 Comments